IP77-06: Do concomitant auto-immune disorders alter the tumor immune microenvironment and subsequent effectiveness of BCG in non-muscle invasive bladder cancer: a mixed methods study

IP77-06: Do concomitant auto-immune disorders alter the tumor immune microenvironment and subsequent effectiveness of BCG in non-muscle invasive bladder cancer: a mixed methods study

Monday, May 18, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)
147A
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!